Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significanceHongyang Shu, Ning Zhou, Jia Cheng et al.|Cardiovascular Diabetology|2023Cited by 113
Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPKHongyang Shu, Ning Zhou, Wenjun Zhang et al.|Frontiers in Pharmacology|2021Cited by 34
Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoterHongyang Shu, Ning Zhou, Yizhong Peng et al.|Acta Pharmacologica Sinica|2022Cited by 21
Unraveling the Nexus between Obesity and Atrial Fibrillation: Mechanistic Insights and Clinical ImplicationsHongyang Shu, Ning Zhou, Jia Cheng et al.|Unknown|2024Cited by 0
Heart Failure and Its Treatment with TrimetazidineHongyang Shu, Dao Wen Wang, Yizhong Peng et al.|Unknown|2024Cited by 0